Press Releases

WASHINGTON, Nov. 4 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) sent a letter Thursday asking the Justice Department and the Federal Trade Commission to investigate potential collusion among pharmaceutical companies that manufacture diabetes products. The prices of insulin medications, which are used by about 6 million Americans to treat diabetes, have skyrocketed in recent years. The cost of

WASHINGTON, Nov. 2 – Sen. Bernie Sanders applauded President Barack Obama for saying Tuesday that the U.S. Army Corps of Engineers is examining ways to reroute the Dakota Access Pipeline to avoid culturally sensitive lands of the Standing Rock Sioux tribe. “I am very grateful to President Obama for listening to the voices of Native Americans and their many allies

BURLINGTON, Vt., Oct. 28 — U.S. Sen. Bernie Sanders (I-Vt.) sent a letter to President Barack Obama Friday requesting he intervene to protect Native Americans peacefully protesting the Dakota Access Pipeline. At least 140 people were arrested at the construction site in Cannon Ball, N.D., Wednesday after militarized police moved in with tanks and riot gear, using sound cannons, pepper

BURLINGTON, Vt., Oct. 26 – Warning of a “gross concentration of power” in the news media, U.S. Sen. Bernie Sanders (I-Vt.) sent a letter Wednesday urging the U.S. Department of Justice to block a proposed merger of AT&T and Time Warner, Inc. “This proposed merger is just the latest effort to shrink our media landscape, stifle competition and diversity of

BURLINGTON, Vt., Oct. 20 – U.S. Sen. Bernie Sanders (I-Vt.) announced Thursday that the U.S. Department of Labor awarded $4.3 million to a St. Albans-based nonprofit, Vermont Associates for Training and Development, to expand their efforts to provide job training and employment services for low-income seniors. In addition to helping Vermonters, the boost in federal funding will allow Vermont Associates

WASHINGTON, Oct. 20 — Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) sent a letter to ARIAD Pharmaceuticals, Inc. Thursday requesting information about why the company has increased the price of leukemia drug Iclusig four times in 2016 to $199,000 a year. ARIAD has raised the price of the drug by more than $80,000 over the last several years.